Skip to main content

Table 11 Characteristics of participants in included observational studies

From: Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review

Reference Country Male sex Age Comorbidity Number of coincident medications Functional status/frailty level Cognitive status
Burton 2006 [48] Scotland 51% Mean age 77 years, subgroup analysis age ≥ 75 years Not reported Not reported Not reported Not reported
Sam 2004 [59] USA 49.8% Men: mean age 72.5 years. Women: mean age 79 years, 100% older than 65 years ASA/warfarin/none: congestive heart failure 14%/22%/65%, previous myocardial infarction 20%/18%/62%, stroke 25%/28%/46%, diabetes mellitus 25%/23%/53%, hypertension 21%/21%/58%, alcohol use 19%/26%/55% Not reported Not reported Not reported
  1. Note: ACE angiotensin-converting-enzyme, ASA acetylsalicylic acid, AT Angiotensin, NSAID nonsteroidal anti-inflammatory drugs